Invasive fungal infections in Neonatal Intensive Care Units of Southern Italy: A multicentre regional active surveillance (Aurora Project)

Journal of Preventive Medicine and Hygiene

Volumn 51, Issue 3, 2010, Pages 125-130

  Montagna, Maria Teresa ^a   Lovero, G ^a   De Giglio, O ^a   Iatta, R ^a   Caggiano, G ^a   Montagna, O ^b   Laforgia, N ^b   Cuna, T ^b   Rella, A ^b   Coretti, C ^b   Natale, B ^c   Corso, G ^c   Gagliardi, G ^c   Barberio, E ^c   Del Vecchi, A ^c   Longo, R ^d   Giannuzzo, S ^d   Faneschi, M L ^d   Pizzolante, M ^d   Gatta, A ^e   Labonia, M ^e   Li Bergoli, M ^e   Vitacco, V ^f   Saracco, G ^f   Morelli, E ^f   Panetta, P ^f   Presta, G ^g   Greco, F ^g   Leo, L ^g   Lobreglio, G ^g   more..

^a Hygiene Section   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c DI VENERE HOSPITAL   (Italy)

^d VITO FAZZI HOSPITAL   (Italy)

^e CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^f SS Annunziata Hospital   (Italy)

^g Card G Panico Hospital   (Italy)

Author keywords

Fungal infection; Incidence; NICU; Surveillance

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; BETA 1,3 GLUCAN; CANDIDA ANTIGEN; CASPOFUNGIN; FLUCONAZOLE; FUNGUS ANTIBODY; ITRACONAZOLE; MANNAN; POSACONAZOLE; VORICONAZOLE;

ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDEMIA; CENTRAL VENOUS CATHETER; CHILD; CHRYSEOBACTERIUM MENINGOSEPTICUM; FEMALE; FUNGUS ISOLATION; GESTATIONAL AGE; HUMAN; INFANT; INVASIVE CANDIDIASIS; ITALY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; TOTAL PARENTERAL NUTRITION;

CANDIDA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; ITALY; LENGTH OF STAY; MALE; MYCOSES; POPULATION SURVEILLANCE; PROGRAM EVALUATION; PROSPECTIVE STUDIES;

EID: 79251588738     PISSN: 11212233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Benjamin DK Jr, Stoll BJ. Infection in late preterm infants. Clin Perinatol 2006;33:871-82.
2. Chapman RL. Prevention and treatment of Candida infections in neonates. Semin Perinatol 2007;31:39-46.
3. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285-91.
4. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 2004;17:638-80.
5. Levy I, Shalit I, Askenazi S, et al. Duration and outcome of persistent candidaemia in newborn infants. Mycoses 2006;49:197-201.
6. Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006;117:84-92.
7. Cotten CM, McDonald S, Stoll B, et al. National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006;118:717-22.
8. Rodriguez D, Almirante B, Park BJ, et al. Candidemia in neonatal intensive care units: Barcellona, Spain. Pediatr Infect Dis J 2006;25:224-9.
9. Al-Sweih N, Khan Z, Khan S, et al. Neonatal candidemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility. Mycoses 2008;52:518-23.
10. Kuzucu C, Durmaz R, Otlu B, et al. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey. New Microbiol 2008;31;401-8.
11. van Asbeck EC, Huang YC, Markham AN, et al. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia 2007;164:287-93.
12. Reissa E, Lasker BA, Iqbal NJ, et al. Molecular epidemiology of Candida parapsilosis sepsis from outbreak investigations in neonatal intensive care units. Infect Genet Evol 2008;8:103-9.
13. Hernández-Castro R, Arroyo-Escalante S, Carrillo-Casas EM, et al. Outbreak of Candida parapsilosis in a neonatal intensive care unit: a health care workers source. Eur J Pediatr 2010;169:783-87.
14. Bendel CM. Nosocomial neonatal candidiasis. Pediatr Infect Dis J 2005;24:831-32.
15. Manzoni P, Farina D, Leonessa M, et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 2006;118:2359-64.
16. Maródi L, Johnston RB Jr. Invasive Candida species disease in infants and children: occurrence, risk factors, management, and innate host defense mechanisms. Curr Opin Pediatr 2007;19:693-97.
17. Castagnola E, Buratti S. Clinical aspects of invasive candidiasis in paediatric patients. Drugs 2009;69(Suppl.1):45-50.
18. Stronati M, Decembrino L. Neonatal invasive candidiasis. Minerva Pediatr 2006;58:537-49.
19. Brecht M, Clerihew L, McGuire W. Prevention and treatment of invasive fungal infection in very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 2009;94:F65-9.
20. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal diseases from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Disease Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
21. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35.
22. Manzoni P, Pedicino R, Stolfi I, et al. Criteria for the diagnosis of systemic fungal infections in newborns: a report from the Task Force on neonatal fungal infections of the GSIN. Pediatr Med Chir 2004;26:89-95.
23. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved Standard, 3rd. ed. CLSI document M27-A3. Wayne, PA: CLSI 2008.
24. Diekema DJ, Messer SA, Boyken LB, et al. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J Clin Microbiol 2009;10:3170-7.
25. Bassetti M, Righi E, Costa A, et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006;6:21.
26. Bedini A, Venturelli C, Mussini C, et al. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect 2006;12:75-80.
27. Asticcioli S, Nucleo E, Perotti G, et al. Candida albicans in a neonatal intensive care unit: antifungal susceptibility and genotypic analysis. New Microbiol 2007;30:303-7.
28. Caggiano G, Iatta R, Laneve A, et al. Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004. Mycoses 2008;51:123-8.
29. Feja KN, Wu F, Roberts K, et al. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr 2005;147:156-61.
30. Blyth CC, Chen SC, Slavin MA, et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 2009;123:1360-8.
31. Castagnola E, Franceschi A, Natalizia AR, et al. Combined antifungal therapy for persistent central venous catheter-related candidemia in extremely low birth weight neonates. J Chemother 2009;21:234-5.
32. Manzoni P, Farina D, Galletto P, et al. Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. J Perinat Med 2007;35:220-6.
33. th ed. Washington, DC: American Society for Microbiology Press 2007, pp. 1762-1788.
34. thed. Washington, DC: American Society for Microbiology Press 2007, pp. 1745-1761.
35. Oliveri S, Trovato L, Betta P, et al. Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin Microbiol Infect 2008;14:391-3.
36. Koo S, Bryar JM, Page JH, et al. Diagnostic performance of the (1-- > 3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis 2009;49:1650-9.
37. Alam FF, Mustafa AS, Khuan ZU. Comparative evaluation of (1,3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infectious Diseases 2007;7:103.
38. Sendid B, Poirot JL, Tabouret M, et al. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol 2002;51:433-42.
39. Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006;42:1735-42.
40. Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009;302:1421-28.
41. Khan ZU, Al-Sweih NA, Ahmad S, et al. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole and fluconazole. J Clin Microbiol 2007;45:2025-7.